About this document
Acneiform Rash Management Guidelines by Devana Maelissa is a document available to read on EtoBox.
Acneiform rash is a common side effect of targeted cancer therapies, occurring in 10-80% of patients within the first 2 weeks of treatment. It is characterized by erythema, edema, and papulopustular eruptions of the face, scalp, chest and other areas. Severe rash increases risks of infection, treatment delays or discontinuation, and reduced quality of life due to pain, distress and impaired mobility. Assessment of rash involves evaluation of color, thickness, moisture, integrity, desquamation, swelling and
- Author
- Devana Maelissa
- Language
- EN